Gts Securities LLC Bristol Myers Squibb CO Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $2.84 Million - $3.74 Million	-70,600 Reduced 37.02%	120,100 $4.99 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $2.2 Million - $2.5 Million	45,900 Added 31.7%	190,700 $10.3 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $281,184 - $335,530	-5,800 Reduced 3.85%	144,800 $7.43 Million
Q3 2023 Nov 15, 2023	BUY	$57.89 - $64.73 $8.72 Million - $9.75 Million	150,600 New	150,600 $8.74 Million

2,400

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.